To investigate the potential role of CAMSAP2 in determining clinical outcomes for HCC, we analyzed its expression in two independent cohorts of human HCC (cohort I, n = 360; cohort II, n = 178) by IHC. The gene discussed is CAMSAP2; the disease is hepatocellular carcinoma.